Skip to main content
VCbacked
Log inGet Started

Serif Bio­med­i­cines

Cambridge, United States

Serif Biomedicines is pioneering Modified DNA as a new type of biotechnology.

$50.0M raised
Apr 2026
Venture - Series Unknown

Top Investors

Flagship Pioneering

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Serif Bio­med­i­cines

How much funding has Serif Bio­med­i­cines raised?
Serif Bio­med­i­cines has raised $50.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Serif Bio­med­i­cines's investors?
Serif Bio­med­i­cines's investors include Flagship Pioneering.
Where is Serif Bio­med­i­cines headquartered?
Serif Bio­med­i­cines is headquartered in Cambridge, United States.
What does Serif Bio­med­i­cines do?
Serif Biomedicines is pioneering Modified DNA as a new type of biotechnology.
What stage is Serif Bio­med­i­cines at?
Serif Bio­med­i­cines is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Serif Bio­med­i­cines — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/serif-biomedicines. Accessed July 2, 2026.
APA
VCBacked. (2026). Serif Bio­med­i­cines — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/serif-biomedicines
Wikipedia (cite web)
{{cite web |title=Serif Bio­med­i­cines — Funding & Investors |url=https://www.vcbacked.co/company/serif-biomedicines |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .